Skip to main content
icon for Flu Hospitalization Rate Week 17, 2026?

Flu Hospitalization Rate Week 17, 2026?

icon for Flu Hospitalization Rate Week 17, 2026?

Flu Hospitalization Rate Week 17, 2026?

85–90 89%

<80 8%

90–95 5%

80–85 3.0%

Polymarket
NUEVO

85–90 89%

<80 8%

90–95 5%

80–85 3.0%

Polymarket
NUEVO

<80

$48 Vol.

8%

80–85

$48 Vol.

3%

85–90

$48 Vol.

89%

90–95

$48 Vol.

5%

95–100

$48 Vol.

3%

100+

$124 Vol.

<1%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders assign an 88.5% implied probability to the 85–90 cumulative flu hospitalization rate per 100,000 population for Week 17 (ending May 2), reflecting CDC FluSurv-NET's Week 15 report of 85.2 overall—the third-highest seasonal cumulative thus far—with a negligible weekly addition of just 0.5 per 100,000, down from 0.7 the prior week. This positioning stems from sharply declining national flu activity, very low outpatient influenza-like illness levels (below baseline), and FluSight ensemble forecasts predicting further drops in laboratory-confirmed hospital admissions amid waning respiratory virus circulation as of late April. Preliminary data face reporting delays, but sustained low transmission dynamics support stability near current levels; Week 16 FluView updates, due imminently, could refine trajectories before resolution.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$363
Fecha de finalización
8 may 2026
Mercado abierto
Apr 30, 2026, 2:36 PM ET
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders assign an 88.5% implied probability to the 85–90 cumulative flu hospitalization rate per 100,000 population for Week 17 (ending May 2), reflecting CDC FluSurv-NET's Week 15 report of 85.2 overall—the third-highest seasonal cumulative thus far—with a negligible weekly addition of just 0.5 per 100,000, down from 0.7 the prior week. This positioning stems from sharply declining national flu activity, very low outpatient influenza-like illness levels (below baseline), and FluSight ensemble forecasts predicting further drops in laboratory-confirmed hospital admissions amid waning respiratory virus circulation as of late April. Preliminary data face reporting delays, but sustained low transmission dynamics support stability near current levels; Week 16 FluView updates, due imminently, could refine trajectories before resolution.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$363
Fecha de finalización
8 may 2026
Mercado abierto
Apr 30, 2026, 2:36 PM ET
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Cuidado con los enlaces externos.

Preguntas frecuentes

"Flu Hospitalization Rate Week 17, 2026?" es un mercado de predicción en Polymarket con 6 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "85–90" con 89%, seguido de "90–95" con 5%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 89¢ implica que el mercado colectivamente asigna una probabilidad de 89% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

"Flu Hospitalization Rate Week 17, 2026?" es un mercado recién creado en Polymarket, lanzado el Apr 30, 2026. Como mercado nuevo, esta es tu oportunidad de ser uno de los primeros operadores en establecer las probabilidades y las señales de precio iniciales del mercado. También puedes guardar esta página en marcadores para seguir el volumen y la actividad de trading a medida que el mercado gana tracción.

Para operar en "Flu Hospitalization Rate Week 17, 2026?", explora los 6 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "Flu Hospitalization Rate Week 17, 2026?" es "85–90" con 89%, lo que significa que el mercado asigna una probabilidad de 89% a ese resultado. El siguiente resultado más cercano es "90–95" con 5%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "Flu Hospitalization Rate Week 17, 2026?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.